Hamill John P. 4
4 · Aprea Therapeutics, Inc. · Filed Mar 28, 2024
Insider Transaction Report
Form 4
Hamill John P.
SrVP/CFO/Prin Fin & Acct Ofcr
Transactions
- Award
Common Stock
2024-03-28+3,365→ 18,868 total - Award
Stock Options (Right to Buy)
2024-03-28+13,460→ 13,460 totalExercise: $6.69Exp: 2024-03-28→ Common Stock (13,460 underlying)
Footnotes (2)
- [F1]These shares represent restricted stock units ("RSUs") and shall vest and be settled in the Issuer's common stock ("Common Stock") in three (3) equal annual installments beginning on March 28, 2025, until vested in full, subject to the reporting person's continued employment through and including the applicable vesting dates and subject to acceleration under certain conditions.
- [F2]Twenty-five percent of these options vest on March 28, 2025, with the remaining options vesting ratably over the following 36 months, subject to the reporting person's continued employment through and including the applicable vesting dates and subject to acceleration under certain conditions.